Nanotechnology Now - Press Release: "White Paper Now Available from Veriteq, a Vaisala Company"

Home > Press > White Paper Now Available from Veriteq, a Vaisala Company

Abstract:
Compliance, Risk and Cost of Ownership Comparisons for Medical Device Sterile Products, Materials and Components Continuous Monitoring

White Paper Now Available from Veriteq, a Vaisala Company

Finland | Posted on November 12th, 2010

Quality managers in plastics, electronics, nanotech, medical products and medical device companies can now obtain a guide to evaluating costs of monitoring critical environments while controlling risk factors from Veriteq, a Vaisala company. Copies of this no-cost white paper Compliance, Risk and Cost of Ownership Comparisons for Medical Device Sterile Products, Materials and Components Continuous Monitoring —Wired, Wireless and Standalone Monitoring Instruments can be obtained by writing to

Six different modalities used in medical device and medical products' materials and components industries for continuous monitoring—chart recorders, standalone data loggers, wired LAN networks with UPS backups, wired LAN networks using Power over Ethernet; WiFi; and Wireless Mesh—are systematically explained and compared in terms of costs of ownership and risks of non-compliance and loss in the context of today's regulatory environment.

Ken Appel, Manager of Regulated Industries for Veriteq, a Vaisala company, and author of the white paper explains that he wrote it to address the commonly overlooked sources of human error inherent in various monitoring modalities and to provide a systematic way for quality managers to weigh the pros and cons of different approaches to continuous monitoring. Mr. Appel says, "Whether you choose one method over the other or a combination, you will have to decide what makes the most sense in your organization. There is no one solution that fits every situation. Always though, a concern is to address the level of risk you can afford, and to know what these risks are. Understandably, these decisions do not occur in a vacuum. Physical plant layout, existing IT infrastructure, support resources and management buy-in to name a few, will likely influence your path."

To obtain a copy of the white paper write to

For a preview of the white paper, visit www.veriteq.com/cost-ownership-med-dev/

####

About Veriteq
Veriteq is a part of Vaisala, global leader in environmental and industrial measurement. With solutions that deliver fail-safe records for temperature, humidity and other parameters, we provide high performance solutions for validating and monitoring GMP-regulated and other controlled environments. Vaisala acquired Veriteq in April, 2010, building on more than 70 years of reliability in measuring critical environments. Headquartered in Finland, Vaisala is listed on the NASDAQ OMX Helsinki.

For more information, please click here

Contacts:
For editorial inquiries, please contact:
Amy Munice
ALM Communications
+773-862-6800
(skype)ALMCommunications

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: